Advertisement

Topics

The National Hemophilia Foundation Company Profile

21:38 EST 17th November 2017 | BioPortfolio

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.


News Articles [1366 Associated News Articles listed on BioPortfolio]

Ten new awards from the National Science Foundation

(National Science Foundation) Ten new awards from the National Science Foundation (NSF) totaling $14 million will enable biologists to develop enhanced genomic tools that can reveal new insights into ...

Hundreds Gather at National AIDS Memorial to Dedicate Newly Built Hemophilia Memorial Circle to Honor Lives Lost in Early Days of AIDS Epidemic

SAN FRANCISCO, Sept. 16, 2017 /PRNewswire-USNewswire/ -- Hundreds of hemophilia advocates and survivors came together at the National AIDS Memorial to dedicate the Hemophilia Memorial Circle, a b...

NSF EPSCoR awards new projects

(National Science Foundation) The National Science Foundation (NSF) has made eight awards totaling $41.7 million for projects aimed at building capacity to research a national priority area: understan...

ASCRS to celebrate National Sight Week in October

National Sight Week will be observed from Oct. 15 to 21, the American Society of Cataract and Refractive Surgery Foundation announced. The weeklong celebration of volunteerism is meant to encourage me...

New Data to be Presented at ISTH Underscore Bioverativ's Commitment to Advance Hemophilia Care

19 hemophilia-related abstracts will be presented, demonstrating the company's commitment to innovation and addressing serious unmet patient needs in hemophilia Bioverativ Inc. (NASDAQ: BIVV), a g...

Increased sample size in 2015 survey

(National Science Foundation) The National Science Foundation's National Center for Science and Engineering Statistics has more than doubled the sample size of its 2015 Survey of Doctorate Recipients ...

NSF funds new multidisciplinary approaches to study the brain

(National Science Foundation) The National Science Foundation made 19 awards to cross-disciplinary teams from across the United States to conduct innovative research focused on neural and cognitive sy...

NSF announces 14 new PIRE awards to support scientific collaboration in 24 countries

(National Science Foundation) The National Science Foundation (NSF) is pleased to announce 14 new Partnerships for International Research and Education (PIRE) awards, totaling more than $66 million ov...

Drugs and Medications [516 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [1189 Associated PubMed Articles listed on BioPortfolio]

Evaluating the psychosocial impact of hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

The needs of individuals living with hemophilia B, especially those with mild or moderate hemophilia and affected females, are not well understood. The Bridging Hemophilia B Experiences, Results and O...

Mortality caused by intracranial bleeding in non-severe hemophilia A patients: reply.

With great interest we read the letter of Dr. Patil et al. (1) in which they present the number and percentage of hemophilia patients registered in the Mumbai hemophilia center who died from (intracr...

Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

The Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) initiative was launched in an effort to address specific gaps in the understanding of the psychosocial impact...

Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

The psychosocial impact of hemophilia on work was recently investigated in the Hemophilia Experiences, Results and Opportunities (HERO) study. The findings revealed that hemophilia had an impact for a...

Impact of mild to severe hemophilia on engagement in recreational activities by US men, women, and children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.

The psychosocial impact of hemophilia on activities was recently investigated in the Hemophilia Experiences, Results and Opportunities (HERO) study (675 people with hemophilia and 561 caregivers of ch...

Clinical Trials [1318 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

To correlate the HLA type and genetic defect with hemophilia A.

Epidemiology and Immunology of Hemophilia A Inhibitors

To determine the risk factors associated with inhibitor formation in hemophilia A and to study the mechanism of tolerance in the murine hemophilia A model.

Understanding Hemophilia A and B Drug Dosage Administration Patterns

Study Design A prospective observational, cross-sectional epidemiological study in U.S. site-based clinical practice settings. 30 sites will enroll approximately 300 patients ...

Companies [2300 Associated Companies listed on BioPortfolio]

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

Hemophilia Foundation of Michigan

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treat...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

More Information about "The National Hemophilia Foundation" on BioPortfolio

We have published hundreds of The National Hemophilia Foundation news stories on BioPortfolio along with dozens of The National Hemophilia Foundation Clinical Trials and PubMed Articles about The National Hemophilia Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The National Hemophilia Foundation Companies in our database. You can also find out about relevant The National Hemophilia Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record